Inventor · disambiguated record
Robert D. Mass
Also filed as: MASS ROBERT D
5 granted patents·56 pending applications·185 citations·filing 2001–2023
87Inventor score
Top patents by PatentIndex Score
61 records- 0196US7993834B2Detection of ErbB2 gene amplification to increase the likelihood of the effectiveness of ErbB2 antibody breast cancer therapyGENENTECH INC·Filed 2007·Granted Aug 9, 2011·65 cites·6 claims
- 0295US8076066B2Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapyMASS ROBERT D·Filed 2007·Granted Dec 13, 2011·39 cites·6 claims
- 0393US8592152B2Gene detection assay for improving the likelihood of an effective response to an EGFR antagonist cancer therapyMASS ROBERT D·Filed 2011·Granted Nov 26, 2013·24 cites·6 claims
- 0493US8440402B2Gene detection assay for improving the likelihood of an effective response to a HER2 antibody cancer therapyMASS ROBERT D·Filed 2011·Granted May 14, 2013·21 cites·6 claims
- 0593US7622115B2Treatment with anti-VEGF antibodiesGENENTECH INC·Filed 2007·Granted Nov 24, 2009·36 cites·5 claims
- 0684US2023218755A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2023·Application pending·0 cites
- 0774US2021015918A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2020·Application pending·0 cites
- 0873US2019307881A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2019·Application pending·0 cites
- 0971US2020171148A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2020·Application pending·0 cites
- 1070US2010226880A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2009·Application pending·0 cites
- 1169US2014178363A1Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumorsGENENTECH INC·Filed 2013·Application pending·0 cites
- 1269US2009246173A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2009·Application pending·0 cites
- 1369US2009239236A1Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapyGENENTECH INC·Filed 2009·Application pending·0 cites
- 1469US2019070291A1GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN ErbB ANTAGONIST CANCER THERAPYGENENTECH INC·Filed 2018·Application pending·0 cites
- 1569US2009191215A1Treatment with anti-VEGF AntibodiesGENENTECH INC·Filed 2009·Application pending·0 cites
- 1668US2018221473A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2017·Application pending·0 cites
- 1767US2009010881A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 1867US2008248049A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 1967US2008292630A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2067US2008248033A1VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumorsGENENTECH INC·Filed 2007·Application pending·0 cites
- 2167US2008279860A1Treatment With Anti-VEGF AntibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2267US2008267968A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2367US2008241148A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2467US2009053216A1Treatment with Anti-VEGF AntibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2567US2009010883A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2667US2008292631A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2008·Application pending·0 cites
- 2766US2017360928A1GENE DETECTION ASSAY FOR IMPROVING THE LIKELIHOOD OF AN EFFECTIVE RESPONSE TO AN ErbB ANTAGONIST CANCER THERAPYGENENTECH INC·Filed 2017·Application pending·0 cites
- 2866US2014178369A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2013·Application pending·0 cites
- 2965US2014248609A1Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapyGENENTECH INC·Filed 2013·Application pending·0 cites
- 3065US2008166351A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2007·Application pending·0 cites
- 3164US2016304594A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2016·Application pending·0 cites
- 3263US2007160608A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3363US2007202516A1Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapyGENENTECH INC·Filed 2006·Application pending·0 cites
- 3463US2016108116A1Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumorsGENENTECH INC·Filed 2015·Application pending·0 cites
- 3562US2007036753A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3662US2018208647A1Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumorsGENENTECH INC·Filed 2017·Application pending·0 cites
- 3762US2007036754A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3862US2007071718A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 3962US2013028862A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2012·Application pending·0 cites
- 4062US2007031413A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4162US2007154483A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4262US2007148178A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4362US2007071749A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4462US2007025999A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4562US2007071748A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4662US2008248036A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4762US2006228745A1Gene detection assay for improving the likelhood of an effective response to an ErbB antagonist cancer therapyGENENTECH INC·Filed 2006·Application pending·0 cites
- 4862US2007148177A1Treatment with anti-vegf antibodiesGENENTECH INC·Filed 2006·Application pending·0 cites
- 4961US2011052576A1Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumorsGENENTECH INC·Filed 2010·Application pending·0 cites
- 5061US2012148584A1Vegf-specific antagonists for adjuvant and neoadjuvant therapy and the threatment of early stage tumorsFERRARA NAPOLEONE·Filed 2012·Application pending·0 cites
Showing the top 50 of 61 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →